Ph.D. Anamarija Slović, GENERA partner researcher, participated in the conference called "4th Conference on Next Generation Sequencing for Adventitious Virus Detection in Biologics for Humans and Animals" held in Frankfurt in the period from December 3-5, 2024. and where the main topic was the introduction of new methods (next generation sequencing) into regulatory guidelines that enable faster testing of biotechnological preparations without the need to use them in the process in vitro and in vivo tests.
